CD63 and depressive symptom measurement: A study examining type 2 diabetes mellitus (T2DM) found significantly higher CD63 expression in T2DM individuals with comorbid depression compared to those with diabetes alone (48), suggesting that CD63 could serve as a potential biomarker for depression, particularly in individuals with comorbid T2DM.